all report title image
  • Published On : Aug 2022
  • Code : CMI379
  • Industry : Medical Devices
  • Pages : 190
  • Formats :

Digital pathology, also known as ‘virtual microscopy’, is a dynamic, image-based environment that enables the acquisition, management, and interpretation of pathology information generated from a digitized glass slide. Digital pathology is a potential method for diagnosis of several chronic and infectious diseases like cardiovascular disease, cancer and hepatic fibrosis.

Global digital pathology market is estimated to be valued at US$ 666.0 million in 2022 and is expected to exhibit a CAGR of 7.7% during the forecast period (2022-2030).

Figure 1. Global Digital Pathology Market Share (%), by End User, 2022

Digital Pathology  | Coherent Market Insights

Increasing prevalence of chronic diseases and the need for early diagnosis of such conditions is expected to boost growth of market over the forecast period.

Increasing prevalence of chronic diseases and the need for early diagnosis of such conditions is expected to boost growth of market over the forecast period. For instance, according to the World Health Organization (WHO), 18.1 million new cases and 9.6 million deaths were registered due to cancer in 2018. In 2019, according to American Heart Association, Cardiovascular disease (CVD) accounted for 874,613 deaths in the U.S. in 2019. In 2019, stroke accounted for approximately 1 of every 19 deaths in the U.S. In 2020, there were 7.08 million deaths attributable to cerebrovascular disease worldwide (3.48 million deaths from ischemic stroke, 3.25 million deaths from intracerebral hemorrhage (ICH), and 0.35 million from subarachnoid hemorrhage).

CMI table icon

Digital Pathology Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 666.0 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 7.7% 2030 Value Projection: US$ 1,207.8 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Offering: Scanner (Bright Field Scanner, Fluorescence Scanner), Software (Image Analysis Platform (On-Premises Delivery, Cloud Based Delivery)), DPIS (On-Premises Delivery, Cloud Based Delivery), Services (Installation and Integration, Maintenance Services, Consulting Services)
  • By Application: Hematology, Chemical Pathology, Histopathology, Medical Microbiology
  • By End User: Hospitals, Laboratories (Private Laboratories, Public Laboratories), Research Centers
Companies covered:

Perkin Elmer, Inc., Definiens AG, Sectra ABss, Koninklijke Philips N.V., Paige, GE Healthcare, Inspirata Co., Ventana Medical Systems, Inc., Leica Biosystems, 3D-Histech Ltd., and Hamamatsu Photonics, K.K. 

Growth Drivers:
  • Increasing prevalence of chronic diseases and the need for early diagnosis of such conditions 
  • Increasing incidences of infectious diseases
Restraints & Challenges:
  • High cost of digital pathology devices and equipment

Figure 2. Global Digital Pathology Market Share (%), by Region, 2022

Digital Pathology  | Coherent Market Insights

Increasing incidences of infectious diseases is propelling growth of the global digital pathology market.

Increasing incidences of infectious diseases is also propelling growth of the global digital pathology market. For instance, according to the WHO, July 2018 Factsheet, around 71 million people had chronic hepatitis C infection worldwide and around 3,99 million deaths occur annually from hepatitis C, mostly due to cirrhosis and hepatocellular carcinoma. According to the American Heart Association, in 2020, an estimated 1.64 million deaths were attributed to diabetes globally. This represents an age-standardized mortality rate of 20.07 per 100,000. The World Heart Federation predicts more than 23 million Cardiovascular Disease-related deaths per year by 2030.  Furthermore, according to the Centers for Disease Control and Prevention, in 2019, approximately 18.2 million U.S. adults had coronary artery disease, and 805,000 Americans have a heart attack each year.

Global Digital Pathology Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs and medical devices by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs and medical devices from one place to another.

However, the COVID-19 pandemic had a positive impact on the global digital pathology market, owing to the increasing need of digital pathology for the diagnosis of COVID-19 in the suspected patients. For instance, in January 2021, Leica Bio systems, a biotechnology company, provided digital pathology platform to various pathology labs to monitor the COVID-19. Moreover, in July 2020, according to National Center for Biotechnology Information, COVID-19 pandemic has had a profound impact on routine pathology services. Digital pathology can play a role ‘to safeguarding clinical services and pathology-based research in the current climate. This digital-based approach to diagnosis represents a new way in the evaluation of surgical pathology slides from formalin-fixed paraffin-embedded tissue (FFPE). At the same time, it can have an effect on ‘social interaction’ among pathologists, including their interplay with clinicians and even patients.

Global Digital Pathology Market: Key Developments

In March 2022, F. Hoffmann-La Roche AG, a pharmaceutical company, collaborated with Bristol Myers Squibb, a pharmaceutical company, to support the advancement of two assays for use in clinical trials with the development and deployment of two new digital pathology algorithms. In the first project under this collaboration, Roche Digital Pathology is creating an Artificial Intelligence-based image analysis algorithm to aid pathologists in interpreting the on-market VENTANA PD-L1 (SP142) Assay. Bristol Myers Squibb would use this algorithm to generate biomarker data from clinical trial samples. In the second project, F. Hoffmann-La Roche AG would leverage its announced open environment collaboration with PathAI to integrate a PathAI-developed algorithm for CD8 biomarker analysis into the NAVIFY Digital Pathology workflow software

Global Digital Pathology Market: Restraint

The major factors that hinder growth of the global digital pathology market include high cost of digital pathology devices and equipment. For instance, in March 2019, according to the data published by the National Center for Biotechnology Information, the overall cost of implementation of digital pathology can be around US$ 150,000 globally. Other expenses also involve maintenance and training costs.

Key Players

Major players operating in the global digital pathology market include Perkin Elmer, Inc., Definiens AG, Sectra ABss, Koninklijke Philips N.V., Paige, GE Healthcare, Inspirata Co., Ventana Medical Systems, Inc., Leica Biosystems, 3D-Histech Ltd., and Hamamatsu Photonics, K.K.

Digital pathology involves management, sharing, acquisition, and interpretation of pathology information in a digital format. Glass slides are scanned with a scanning device which provides a high resolution digital image. This digital image is then viewed on a computer or mobile screen. Technologically advanced digital pathology scanners are available in market, which can capture high quality images of entire glass slides. These slides then can be shared over different networks remotely through digital pathology software applications. Advancement in digital pathology market such as advent of high quality digital scanners, analysis tools, and implementation of networking in digital pathology has driven growth of market. Increasing advancements in whole slide imaging (WSI), Laboratory information system (LIS) and laboratory information management system (LIMS) interfacing, high speed networking, and powerful software applications are expected to support the global digital pathology market growth over the forecast period. 

Market Dynamics

Increasing Research &Development in cancer is expected to offer lucrative growth opportunities for players in the global digital pathology market. For instance, in December 2019, Cancer Research U.K. and Vaccitech Oncology Limited announced a partnership to develop a novel immunotherapeutic vaccine strategy for patients with lung cancer. Furthermore, in May 2022, international medical imaging IT and cybersecurity company Sectra signed a digital pathology contract with Erasmus University Medical Center (Erasmus MC) in the Netherlands.

Moreover, increasing approval of digital pathology by regulatory bodies is expected to drive the global digital pathology market over the forecast period. For instance, in March 2021, Huron Digital Pathology, based in Canada, had received a CE-IVD mark for its high throughput TissueScope iQ 400 slide whole slide scanner. The CE mark indicates that the TissueScope iQ scanner complies with the European In Vitro Diagnostic Regulations. With this certification, Huron Digital Pathology accelerated its entry into the diagnostic pathology market in Europe and other key geographies globally to help laboratories keep pace with the rising cancer burden.

Key features of the study:

  • This report provides an in-depth analysis of the global digital pathology market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global digital pathology market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Perkin Elmer, Inc., Definiens AG, Sectra ABss, Koninklijke Philips N.V., Paige, GE Healthcare, Inspirata Co., Ventana Medical Systems, Inc., Leica Biosystems, 3D-Histech Ltd., and Hamamatsu Photonics, K.K.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global digital pathology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital pathology market

Detailed Segmentation:

  • Global Digital Pathology Market, By Offering:
    • Scanner
      • Bright Field Scanner
      • Fluorescence Scanner
    • Software
      • Image Analysis Platform
        • On-Premises Delivery
        • Cloud Based Delivery
    • DPIS
      • On-Premises Delivery
      • Cloud Based Delivery
    • Services
      • Installation and Integration
      • Maintenance Services
      • Consulting Services
  • Global Digital Pathology Market, By Application:
    • Hematology
    • Chemical Pathology
    • Histopathology
    • Medical Microbiology
  • Global Digital Pathology Market, By End User:
    • Hospitals
    • Laboratories
      • Private Laboratories
      • Public Laboratories
    • Research Centers
  • Global Digital Pathology Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Perkin Elmer, Inc. *
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Definiens AG
    • Sectra ABss
    • Koninklijke Philips N.V.
    • Paige
    • GE Healthcare
    • Inspirata Co.
    • Ventana Medical Systems, Inc.
    • Leica Biosystems
    • 3D-Histech Ltd.
    • Hamamatsu Photonics, K.K.

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The market size is estimated to be valued at US$ 666.0 million in 2022 and is expected to exhibit a CAGR of 7.7% between 2022 and 2030.
Factors such as increasing prevalence of chronic diseases and the need for early diagnosis of such conditions and increasing incidences of infectious diseases are expected to drive the market growth.
Laboratories is the leading end user segment in the market.
The major factors hampering growth of the market include high cost of digital pathology devices and equipment.
Major players operating in the market include Perkin Elmer, Inc., Definiens AG, Sectra ABss, Koninklijke Philips N.V., Paige, GE Healthcare, Inspirata Co., Ventana Medical Systems, Inc., Leica Biosystems, 3D-Histech Ltd., and Hamamatsu Photonics, K.K.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo